MARCAINE HYDROCHLORIDE W Drug Patent Profile
✉ Email this page to a colleague
When do Marcaine Hydrochloride W patents expire, and when can generic versions of Marcaine Hydrochloride W launch?
Marcaine Hydrochloride W is a drug marketed by Hospira and is included in one NDA.
The generic ingredient in MARCAINE HYDROCHLORIDE W is bupivacaine hydrochloride; epinephrine bitartrate. There are twelve drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the bupivacaine hydrochloride; epinephrine bitartrate profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for MARCAINE HYDROCHLORIDE W?
- What are the global sales for MARCAINE HYDROCHLORIDE W?
- What is Average Wholesale Price for MARCAINE HYDROCHLORIDE W?
Summary for MARCAINE HYDROCHLORIDE W
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
DailyMed Link: | MARCAINE HYDROCHLORIDE W at DailyMed |